For sufferers with primarily gentle posterior circulation ischemic stroke who don’t obtain thrombectomy, alteplase administered at 4.5 to 24 hours after onset leads to greater frequency of purposeful independence at 90 days in contrast with commonplace medical care, in line with a examine revealed within the April 3 difficulty of the New England Journal of Medication.
Shenqiang Yan, M.D., from the Second Affiliated Hospital of Zhejiang College in Hangzhou, China, and colleagues randomly assigned sufferers with posterior circulation ischemic stroke, with out in depth early hypodensity on computed tomography and with no deliberate thrombectomy, to alteplase (0.9 mg/kg physique weight; most dose, 90 mg) or commonplace medical therapy 4.5 to 24 hours after symptom onset (117 sufferers in every group). The first consequence was purposeful independence (outlined as a rating of 0 to 2 on the modified Rankin scale; scores vary from 0 to six, with greater scores indicating larger incapacity) at 90 days.
The researchers discovered that the share of sufferers with purposeful independence at 90 days was greater within the alteplase group versus the usual therapy group (89.6% versus 72.6%; adjusted danger ratio, 1.16). The incidence of symptomatic intracranial hemorrhage inside 36 hours was 1.7% and 0.9% within the alteplase and commonplace therapy teams, respectively. At 90 days, 5.2% and eight.5% of sufferers within the alteplase and commonplace therapy teams, respectively, had died.
“These results support the use of alteplase in this extended time window if endovascular thrombectomy is not available,” the authors write.
Extra data:
Shenqiang Yan et al, Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours, New England Journal of Medication (2025). DOI: 10.1056/NEJMoa2413344
© 2025 HealthDay. All rights reserved.
Quotation:
Alteplase will increase frequency of purposeful independence after posterior circulation stroke (2025, April 4)
retrieved 4 April 2025
from https://medicalxpress.com/information/2025-04-alteplase-frequency-functional-independence-posterior.html
This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.
